Connor, Clark & Lunn Investment Management Ltd. Novo Nordisk A S Transaction History
Connor, Clark & Lunn Investment Management Ltd.
- $18.8 Billion
- Q3 2024
A detailed history of Connor, Clark & Lunn Investment Management Ltd. transactions in Novo Nordisk A S stock. As of the latest transaction made, Connor, Clark & Lunn Investment Management Ltd. holds 63,912 shares of NVO stock, worth $6.77 Million. This represents 0.04% of its overall portfolio holdings.
Number of Shares
63,912
Previous 155,727
58.96%
Holding current value
$6.77 Million
Previous $22.2 Million
65.76%
% of portfolio
0.04%
Previous 0.1%
Shares
25 transactions
Others Institutions Holding NVO
# of Institutions
1,956Shares Held
320MCall Options Held
5.49MPut Options Held
7.78M-
Jennison Associates LLC20.2MShares$2.14 Billion1.5% of portfolio
-
Morgan Stanley New York, NY14.4MShares$1.52 Billion0.13% of portfolio
-
Bank Of America Corp Charlotte, NC14.3MShares$1.52 Billion0.14% of portfolio
-
Ken Fisher Fisher Asset Management, LLC | Camas, Wa13.3MShares$1.41 Billion0.65% of portfolio
-
Fayez Sarofim & CO Houston, TX12.2MShares$1.29 Billion3.76% of portfolio
About NOVO NORDISK A S
- Ticker NVO
- Exchange OTC
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 2,257,289,984
- Market Cap $239B
- Description
- Novo Nordisk A/S, a healthcare company, engages in the research, development, manufacture, and marketing of pharmaceutical products worldwide. It operates in two segments, Diabetes and Obesity care, and Biopharm. The Diabetes and Obesity care segment provides products in the areas of insulins, GLP-1 and related delivery systems, oral antidiabeti...